The association between CCND1 polymorphisms and NPC risk was firstly reported by Deng et al., which maintained the GG and AG genotypes in NPC patients were significantly higher than those in normal controls [22]. The gene discussed is CCND1; the disease is nasopharyngeal carcinoma.